Skip to main content

Equillium, Inc.

EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746466

No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Equillium, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of EQ: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders28122−5
Shares7.11M3007.32M+214.0K (+3.0%)
Value$41.9M$2.00K$49.9M+$8.07M (+19.3%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Equillium, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to EQ in Q3 2021
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC83,948$573.0K0.12%
Susquehanna International Group, LLP14,130$96.0K0.00%
Citadel Advisors LLC10,909$74.0K0.00%
Koshinski Asset Management, Inc.1,000$6.82K0.00%

Sold out (9)

Institutions that held Equillium, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of EQ in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Goldman Sachs Group Inc218,162$1.28M
First Trust Advisors LP44,238$261.0K
First Republic Investment Management, Inc.10,000$59.0K
UBS Group AG531$3.00K
Panagora Asset Management Inc341$2.00K
Group One Trading, L.P.100$1.00K
Royal Bank of Canada100$1.00K
Tower Research Capital LLC (TRC)166$1.00K
Bank of America Corp7$0

Not filed for Q3 2021 yet (1)

Institutions that held Equillium, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EQ in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC300$2.00K